Good understanding of the pathology in a disease opens the doors to creative ideas for therapy. The main reason for increased community spread with Omicron is a combination of high early viral load and mucosal (upper airway) interferon suppression.
In order to reduce this advantage for the virus, we can pre-empt the interferon response in areas with high viral exposure.
Nasal interferon has been used for many years with success but not got mainstream promotion, probably because the studies were done in China.
Read second paper here >
It will simply cause the cells in the upper airway to stop making proteins which blocks the SARS-COV2 virus from making multiple copies of itself.
Short term strategy with medium and long term gain.
There is more than one way to skin a cat, and multiple avenues to treat and manage COVID-19.